The LTB-LTBR axis is known to be both pathogenic and drug-responsive across multiple autoimmune-affected organs (skin, joints, eyes), reinforcing its relevance to autoimmunity and highlighting its potential as a therapeutic target in immune-mediated CKD40,41. The gene discussed is LTBR; the disease is Autoimmunity.